Pure Global

Amylase Quantitative Testing Drug - Vietnam Registration 240002954/PCBB-HN

Access comprehensive regulatory information for Amylase Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại B medical device is registered under number 240002954/PCBB-HN and manufactured by Abbott Ireland Diagnostics Division. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN ABBOTT LABORATORIES GMBH TẠI THÀNH PHỐ HÀ NỘI.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Abbott Ireland Diagnostics Division, and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
1 Competitors
2 Recent Registrations
240002954/PCBB-HN
Registration Details
Vietnam MOH Registration: 240002954/PCBB-HN
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Amylase Quantitative Testing Drug
VN: Thuốc thử xét nghiệm định lượng amylase
Risk Class TBYT Loại B

Registration Details

240002954/PCBB-HN

000.00.19.H26-241015-0004

Amylase2

Technical Details

Amylase2 test is used to quantify amylase in human serum, plasma, or urine on the Alinity c analyzer. Amylase2 test is primarily used to support the diagnosis and treatment of pancreatitis (inflammation of the pancreas).

Dates and Status

Oct 30, 2024

Companies Making Similar Products
Companies providing products similar to "Amylase Quantitative Testing Drug"